Simulation Environment to Evaluate Closed-loop Insulin Delivery Systems in Type 1 Diabetes

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2010 Feb 20

PMID 20167177

Citations 47

Authors

Malgorzata E Wilinska

Ludovic J Chassin

Carlo L Acerini

Janet M Allen

David B Dunger

Roman Hovorka

Affiliations

Soon will be listed here.

Abstract

Background: Closed-loop insulin delivery systems linking subcutaneous insulin infusion to real-time continuous glucose monitoring need to be evaluated in humans, but progress can be accelerated with the use of in silico testing. We present a simulation environment designed to support the development and testing of closed-loop insulin delivery systems in type 1 diabetes mellitus (T1DM).

Methods: The principal components of the simulation environment include a mathematical model of glucose regulation representing a virtual population with T1DM, the glucose measurement model, and the insulin delivery model. The simulation environment is highly flexible. The user can specify an experimental protocol, define a population of virtual subjects, choose glucose measurement and insulin delivery models, and specify outcome measures. The environment provides graphical as well as numerical outputs to enable a comprehensive analysis of in silico study results. The simulation environment is validated by comparing its predictions against a clinical study evaluating overnight closed-loop insulin delivery in young people with T1DM using a model predictive controller.

Results: The simulation model of glucose regulation is described, and population values of 18 synthetic subjects are provided. The validation study demonstrated that the simulation environment was able to reproduce the population results of the clinical study conducted in young people with T1DM.

Conclusions: Closed-loop trials in humans should be preceded and concurrently guided by highly efficient and resource-saving computer-based simulations. We demonstrate validity of population-based predictions obtained with our simulation environment.

Citing Articles

Digital Twins in Type 1 Diabetes: A Systematic Review.

Cappon G, Facchinetti A J Diabetes Sci Technol. 2024; :19322968241262112.

PMID: 38887022 PMC: 11572256. DOI: 10.1177/19322968241262112.

The Application of Digital Technologies and Artificial Intelligence in Healthcare: An Overview on Nutrition Assessment.

Salinari A, Machi M, Armas Diaz Y, Cianciosi D, Qi Z, Yang B Diseases. 2023; 11(3).

PMID: 37489449 PMC: 10366918. DOI: 10.3390/diseases11030097.

A simple modeling framework for prediction in the human glucose-insulin system.

Sirlanci M, Levine M, Low Wang C, Albers D, Stuart A Chaos. 2023; 33(7).

PMID: 37486667 PMC: 10368459. DOI: 10.1063/5.0146808.

Leeno: Type 1 diabetes management training environment using smart algorithms.

Smaoui M, Lafi A PLoS One. 2022; 17(9):e0274534.

PMID: 36107913 PMC: 9477299. DOI: 10.1371/journal.pone.0274534.

Integrating Multiple Inputs Into an Artificial Pancreas System: Narrative Literature Review.

Hettiarachchi C, Daskalaki E, Desborough J, Nolan C, ONeal D, Suominen H JMIR Diabetes. 2022; 7(1):e28861.

PMID: 35200143 PMC: 8914747. DOI: 10.2196/28861.

References

Hovorka R . Continuous glucose monitoring and closed-loop systems. Diabet Med. 2006; 23(1):1-12. DOI: 10.1111/j.1464-5491.2005.01672.x. View

Patek S, Bequette B, Breton M, Buckingham B, Dassau E, Doyle 3rd F . In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol. 2010; 3(2):269-82. PMC: 2771529. DOI: 10.1177/193229680900300207. View

Hovorka R, Chassin L, Wilinska M, Canonico V, Akwi J, Federici M . Closing the loop: the adicol experience. Diabetes Technol Ther. 2004; 6(3):307-18. DOI: 10.1089/152091504774197990. View

Chassin L, Wilinska M, Hovorka R . Evaluation of glucose controllers in virtual environment: methodology and sample application. Artif Intell Med. 2004; 32(3):171-81. DOI: 10.1016/j.artmed.2004.02.006. View

Wilinska M, Budiman E, Taub M, Elleri D, Allen J, Acerini C . Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol. 2010; 3(5):1109-20. PMC: 2769888. DOI: 10.1177/193229680900300514. View

Worthington D . Minimal model of food absorption in the gut. Med Inform (Lond). 1997; 22(1):35-45. DOI: 10.3109/14639239709089833. View

Hovorka R, Canonico V, Chassin L, Haueter U, Massi-Benedetti M, Federici M . Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas. 2004; 25(4):905-20. DOI: 10.1088/0967-3334/25/4/010. View

Van Herpe T, Espinoza M, Pluymers B, Goethals I, Wouters P, Van den Berghe G . An adaptive input-output modeling approach for predicting the glycemia of critically ill patients. Physiol Meas. 2006; 27(11):1057-69. DOI: 10.1088/0967-3334/27/11/001. View

Kovatchev B, Breton M, Dalla Man C, Cobelli C . In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009; 3(1):44-55. PMC: 2681269. DOI: 10.1177/193229680900300106. View

10.

Silink M . Childhood diabetes: a global perspective. Horm Res. 2002; 57 Suppl 1:1-5. DOI: 10.1159/000053304. View

11.

Wilinska M, Chassin L, Hovorka R . In silico testing--impact on the progress of the closed loop insulin infusion for critically ill patients project. J Diabetes Sci Technol. 2009; 2(3):417-23. PMC: 2769748. DOI: 10.1177/193229680800200311. View

12.

Kovatchev B, Cox D, Gonder-Frederick L, Clarke W . Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care. 1997; 20(11):1655-8. DOI: 10.2337/diacare.20.11.1655. View

13.

Hovorka R, Kremen J, Blaha J, Matias M, Anderlova K, Bosanska L . Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab. 2007; 92(8):2960-4. DOI: 10.1210/jc.2007-0434. View

14.

Eddy D, Schlessinger L . Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003; 26(11):3093-101. DOI: 10.2337/diacare.26.11.3093. View

15.

Andreassen S, Benn J, Hovorka R, Olesen K, Carson E . A probabilistic approach to glucose prediction and insulin dose adjustment: description of metabolic model and pilot evaluation study. Comput Methods Programs Biomed. 1994; 41(3-4):153-65. DOI: 10.1016/0169-2607(94)90052-3. View

16.

Lehmann E, Deutsch T, Roudsari A, Carson E, Sonksen P . Validation of a metabolic prototype to assist in the treatment of insulin-dependent diabetes mellitus. Med Inform (Lond). 1993; 18(2):83-101. DOI: 10.3109/14639239309034472. View

17.

Hovorka R . The future of continuous glucose monitoring: closed loop. Curr Diabetes Rev. 2008; 4(3):269-79. DOI: 10.2174/157339908785294479. View

18.

Bequette B . Editorial: symposium on algorithms for continuous glucose monitoring and control. Diabetes Technol Ther. 2005; 7(1):1-2. DOI: 10.1089/dia.2005.7.1. View

19.

Hovorka R, Chassin L, Ellmerer M, Plank J, Wilinska M . A simulation model of glucose regulation in the critically ill. Physiol Meas. 2008; 29(8):959-78. DOI: 10.1088/0967-3334/29/8/008. View

20.

Wilinska M, Bodenlenz M, Chassin L, Schaller H, Schaupp L, Pieber T . Interstitial glucose kinetics in subjects with type 1 diabetes under physiologic conditions. Metabolism. 2004; 53(11):1484-91. DOI: 10.1016/j.metabol.2004.05.014. View